Baclas, Shennamae H.
HRN: 21-70-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2022
CEFTRIAXONE 1G (VIAL)
08/24/2022
08/28/2022
IVT
2g
OD
S/P LSCS T/c Endometritis
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes